Fred Alger Management’s Regenxbio RGNX Stock Holding History

Fred Alger Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-27,000	Closed	-$1.39M	–	534
2019 Q2	$1.39M	Sell	27,000 -5,000	-16%	-$250K	0.01%	316
2019 Q1	$1.83M	Buy	+32,000	New	+$1.59M	0.01%	287
2018 Q3	–	Sell	-13,000	Closed	-$933K	–	575
2018 Q2	$933K	Buy	+13,000	New	+$621K	﹤0.01%	334
2016 Q4	–	Sell	-14,000	Closed	-$196K	–	516
2016 Q3	$196K	Sell	14,000 -6,000	-30%	-$66.2K	﹤0.01%	374
2016 Q2	$160K	Buy	20,000 +2,000	+11%	+$22.2K	﹤0.01%	418
2016 Q1	$194K	Buy	+18,000	New	+$230K	﹤0.01%	443

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fred Alger Management's RGNX Position: Q3 2019 in Review

Fred Alger Management sold out of Regenxbio (RGNX) in Q3 2019, closing a stake of 27,000 shares — an estimated $1.39M sold.

Fred Alger Management first reported a position in RGNX in Q1 2016 and held it in 6 quarters. The position peaked at $1.83M in Q1 2019. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

Fred Alger Management reported no remaining Regenxbio position as of Q3 2019 after selling out during the quarter.
Fred Alger Management sold 27,000 Regenxbio shares in Q3 2019, an estimated $1.39M.
Fred Alger Management first reported a position in Regenxbio in Q1 2016 and held it in 6 quarters.
Fred Alger Management's Regenxbio position peaked at $1.83M in Q1 2019.
168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Fred Alger Management's 13F filing for Q3 2019, filed 14 Nov 2019.